Showing results (61-70 of 172) with videos related to
Sort By:
Pageof 18
Annual Review of Pathology|September 12, 2009
Mutational heterogeneity in human cancers: origin and consequencesJesse J Salk, Edward J Fox, Lawrence A LoebNature Reviews. Drug Discovery|October 1, 2011
Integrating predictive biomarkers and classifiers into oncology clinical development programmesRobert A Beckman, Jason Clark, Cong ChenCancer Journal (Sudbury, Mass.)|June 10, 2008
Antibody-based therapy for solid tumorsLi Yan, Karl Hsu, Robert A BeckmanProceedings of the National Academy of Sciences of the United States of America|August 12, 2003
Targeted gene evolution in Escherichia coli using a highly error-prone DNA polymerase IManel Camps, Jussi Naukkarinen, Ben P Johnson, et al.Cancer Control : Journal of the Moffitt Cancer Center|September 29, 2020
How Should Cancer Models Be Constructed?Robert A Beckman, Irina Kareva, Frederick R AdlerThe Journal of Biological Chemistry|January 4, 2013
A substitution in the fingers domain of DNA polymerase δ reduces fidelity by altering nucleotide discrimination in the catalytic siteMarc J Prindle, Michael W Schmitt, Fabio Parmeggiani, et al.Cancer|December 13, 2006
Antibody constructs in cancer therapy: protein engineering strategies to improve exposure in solid tumorsRobert A Beckman, Louis M Weiner, Hugh M DavisStatistics in Medicine|March 18, 2017
Estimation of treatment effect in two-stage confirmatory oncology trials of personalized medicinesWen Li, Cong Chen, Xiaoyun Li, et al.Therapeutic Delivery|July 27, 2012
Monoclonal antibody dose determination and biodistribution into solid tumorsRobert A Beckman, Reinhard von Roemeling, Andrew M ScottProceedings of the National Academy of Sciences of the United States of America|August 15, 2012
Impact of genetic dynamics and single-cell heterogeneity on development of nonstandard personalized medicine strategies for cancerRobert A Beckman, Gunter S Schemmann, Chen-Hsiang YeangPageof 18